Poxel SA (LTS:0RA2)
€ 0.1424 0 (0%) Market Cap: 7.53 Mil Enterprise Value: 52.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 8/100

Full Year 2019 Poxel SA Earnings Call Transcript

Mar 26, 2020 / 06:30PM GMT
Release Date Price: €6.17 (+5.16%)
Operator

Ladies and gentlemen, welcome to the Poxel conference call.

I now hand it over to Jonae Barnes. Madam, please go ahead.

Jonae R. Barnes
Poxel S.A. - SVP, IR, Corporate Communications & Public Relations

Good afternoon, everyone, and welcome to Poxel's Full Year 2019 Financial Results and Corporate Update Investor Conference Call. I'm Jonae Barnes, Senior Vice President, Investor Relations and Public Relations. With me on the call, Thomas Kuhn, CEO; Anne Renevot, CFO. Also joining us today are David Moller, CSO; Noah Beerman, President of U.S. Operations and EVP of Business Development; Sébastien Bolze, Chief Operating Officer, EVP, Nonclinical and Manufacturing Operations; and Pascale Fouqueray, EVP, Translational Medicine and Early Clinical Development. We will all be available for Q&A after our call is complete.

Earlier today, we issued a press release which included our full year 2019 financial results and a corporate update. For those of you who don't have a copy, you can access it in the Investor Relations section of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot